Login to Your Account



Other News To Note


Tuesday, February 5, 2013
• Bionomics Ltd., of Adelaide, Australia, presented new data on BNC375, its drug candidate with potential for the treatment of memory loss in Alzheimer's disease, at the 33rd Annual Meeting of the Australian Neuroscience Society in Melbourne, Australia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription